The SF-36 in multiple sclerosis: why basic assumptions must be tested. - Wikidata - wikimedia - TriplyDB

The SF-36 in multiple sclerosis: why basic assumptions must be tested.

The SF-36 in multiple sclerosis: why basic assumptions must be tested.

http://www.wikidata.org/entity/Q35464003

about

A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.Validity and reliability of the Finnish version of the Multiple Sclerosis Impact Scale-29.Health-related quality of life and help seeking among American Indians with diabetes and hypertension.Prevalence and impact of pain in multiple sclerosis: physical and psychologic contributors.Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study.The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).The use of quality of life measures in multiple sclerosis research.A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS)The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure.A comparison of health utility measures for the evaluation of multiple sclerosis treatments A review about the impact of multiple sclerosis on health-related quality of life.Mental Health in Multiple Sclerosis Patients without Limitation of Physical Function: The Role of Physical Activity.Factors Related to Social Support in Neurological and Mental Disorders.Quality of life measures for the palliative care of people severely affected by multiple sclerosis: a systematic review.Are factor analytical techniques used appropriately in the validation of health status questionnaires? A systematic review on the quality of factor analysis of the SF-36.Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88).Rasch analysis of the Multiple Sclerosis Impact Scale MSIS-29.Outcome measurement in neurodegenerative disease: attributes, applications & interpretation.'Hidden' factors influencing quality of life in patients with multiple sclerosis.Beware of the origin of numbers: Standard scoring of the SF-12 and SF-36 summary measures distorts measurement and score interpretations.Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions.Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs.Measuring arm function early after stroke: is the DASH good enough?Construct validity of the SF-12 in three different samples.A short and validated multiple sclerosis-specific health-related quality of life measurement for routine medical practice.Can the ABILHAND handle manual ability in MS?Utilization of health care by patients with multiple sclerosis is based on professional and patient-defined health needs.A pilot investigation of the hypoalgesic effects of transcutaneous electrical nerve stimulation upon low back pain in people with multiple sclerosis.Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists.Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales.Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.Clinical outcome measures for progressive MS trials.A longitudinal study of the SF-36 version 2 in Friedreich ataxia.Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.Randomized trial of a teleconference-delivered fatigue management program for people with multiple sclerosis.The Short Form 36 health survey in spine disease--validation against condition-specific measures.Friedreich's ataxia impact scale: a new measure striving to provide the flexibility required by today's studies.A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis.Illness perception and health-related quality of life in multiple sclerosis.The initial course of daily functioning in multiple sclerosis: a three-year follow-up study.

P2860

Q30547644-41FE43C0-EE8D-4FF2-8129-4649985CA010 Q33917369-1DB45E68-2D43-4715-A6B0-C7404B43E556 Q34078582-2BFBC0AE-7318-4B8E-8633-E50C6089D876 Q34554551-B355AA47-510C-41BE-BF14-CEAF8765E444 Q34656851-E6A35CB8-B8DA-462A-95A7-220FD68B6982 Q34989085-E3043239-7514-4A8D-9B05-2C75C18CC1B2 Q35078168-116480A0-85C6-4E3C-99C3-74EA76C9F238 Q35305266-F7981B01-4067-4FA7-914B-7DBD3871F201 Q35478797-057F4459-8D5B-408C-8EC9-52ADCA1AE9FA Q35483470-D4EEA75E-79EC-49BE-9992-5EAE16B989FD Q35583727-3C581774-18BF-4DE1-9099-B48FD9A9DD80 Q35902453-8A662DE1-3487-49CD-8D85-62CE00AB1E55 Q35930465-63469598-AAB3-47E1-B67C-8AC5E7DB2BEF Q35976064-D2FD3380-25C2-4057-9BB4-2C5EFBF99904 Q36209092-4972C92A-22F6-485E-B006-928ACFB97456 Q36310327-365BB436-6896-42D4-BD11-2DE921443792 Q37252990-9E23075A-2DED-42F7-B3C3-FF7EDC8101E3 Q38570993-22167F8D-AF91-481D-A1D8-B80F49C53CB0 Q38587673-4575116B-D0BC-4DC9-80A9-A3A768BB4C27 Q38667856-90B29009-2B0F-4721-8FFE-EA4A31E543BE Q38682177-1055984C-EC76-48E2-BCFF-7D9771E6934C Q38728373-65F5AABE-94DD-41AB-BBDF-3A73608AE05A Q40730775-E60F5851-58DD-412D-95BA-1E755043DA2A Q44644871-B7167D18-DDE9-453B-AC5D-341427337A40 Q45343221-E510FF5D-74B0-49B1-A226-08C513898431 Q46131825-24D5FEBF-B3CE-4866-95A8-74956F583263 Q46315378-F15D33D9-7278-49D8-8697-7A8C59D8ED2A Q47396669-833F3825-3E1A-49A8-A4D3-6958A2420915 Q47551268-2FF26302-C574-40A0-B02A-D0DFDD9A83D9 Q47679955-CF696559-C13E-43E1-A2FE-AC1F953F0C70 Q47729046-FD7324FB-E7DC-44D5-84F2-2AB207C9E307 Q47892293-862A3A45-9021-4438-B458-A636772C9598 Q47927277-8544570C-AF13-4E46-97BA-A63CC4BF5942 Q47945489-B777C4EA-FAD6-4867-BE1A-256FC477E8C4 Q48672305-2BB5EEE2-CF43-4B85-A86D-B68360FBF3DD Q49112284-E151149F-4CF0-4DB5-9BC7-0F152EC8C274 Q50756497-127B89E3-C881-41AB-8EAD-25A43ADB93CE Q51873437-6E3F8219-1646-4B13-88E4-DA0BFD982AB6 Q51899512-F4001892-5929-465B-91DD-25D78A704482 Q51923734-E95F40A1-290A-40EE-8C93-74834332C59B

P2860

The SF-36 in multiple sclerosis: why basic assumptions must be tested.

http://www.wikidata.org/entity/Q35464003

description

2001 nî lūn-bûn

@nan

2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

The SF-36 in multiple sclerosis: why basic assumptions must be tested.

@ast

The SF-36 in multiple sclerosis: why basic assumptions must be tested.

@en

type

label

The SF-36 in multiple sclerosis: why basic assumptions must be tested.

@ast

The SF-36 in multiple sclerosis: why basic assumptions must be tested.

@en

prefLabel

The SF-36 in multiple sclerosis: why basic assumptions must be tested.

@ast

The SF-36 in multiple sclerosis: why basic assumptions must be tested.

@en

P1433

Q35464003-FCACB570-A854-4CCF-947D-95A4284F4798

P1476

Q35464003-6BFDC026-1191-4F1B-85C0-FB6B0AAFB7CE

P2093

Q35464003-0AEA8A14-20C8-4C2D-A952-1A022E0B639A

Q35464003-4ECFFFB1-B4E4-4953-9717-4644EE237C02

Q35464003-557F53BD-D993-4C3F-928C-EB9BD618978F

Q35464003-9FD1E1DF-DC7D-41FB-A934-EA3F549A9599

Q35464003-A437F0C3-95F4-4496-A559-CD6394C9D809

P2860

Q35464003-005F7A3A-BAEC-4FB2-B2D0-3938B1992DB6

Q35464003-0B2F55FA-53DF-441F-BB7F-A2030268FAD0

Q35464003-0CA4943A-C902-412F-B66E-3E9F00CF884E

Q35464003-137E0333-9BDB-4243-A4F5-583C9780D4B2

Q35464003-16752477-4095-4C5A-8C14-BA0239FB2532

Q35464003-4CA039BD-1B70-48DA-A835-75F4ADF2A31B

Q35464003-4D290BAE-070D-4047-9460-74A17B7F596F

Q35464003-524BE1BC-6814-4332-8713-7C05B785D615

Q35464003-59297A42-8B99-4204-A9FD-811E3DA9746F

Q35464003-682FBAAB-B0A2-43CB-9116-C869763F89D7

P304

Q35464003-F226E5E5-4F69-4A84-BB2A-B68ADC3507B2

P31

Q35464003-91419946-5058-4488-A2AE-DF492C49A59F

P356

Q35464003-9A538B2E-5D89-40F3-9B5B-3826AF245510

P407

Q35464003-1B29D029-2600-4D89-9EA0-CB63B1B60995

P433

Q35464003-B4FCA464-2084-48FB-BBB0-777DBC5D0912

P478

Q35464003-4D8F49A3-E0A8-4D42-A4D5-0C4B1FE285A4

P577

Q35464003-B5C432F1-E8ED-437B-8DA3-FC6A2C1F0409

P5875

Q35464003-9739A465-0D56-4BA2-9017-3DDB5C6A814F

P698

Q35464003-570CE5F4-B17E-4734-B7A9-500841EC3139

P921

Q35464003-5551D46B-5409-40AE-9745-CB8F4BFA82C6

P932

Q35464003-0EC0F0B0-C0A9-4111-9836-F395961C5489

P356

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

The SF-36 in multiple sclerosis: why basic assumptions must be tested.

@en

P2093

A Thompson

http://www.w3.org/2001/XMLSchema#string

D Lamping

http://www.w3.org/2001/XMLSchema#string

J Freeman

http://www.w3.org/2001/XMLSchema#string

J Hobart

http://www.w3.org/2001/XMLSchema#string

R Fitzpatrick

http://www.w3.org/2001/XMLSchema#string

P2860

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data quality, scaling assumptions and score reliability.

Early diagnosis of dementia: neuroimaging.

The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.

New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis.

The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease.

Validating the SF-36 health survey questionnaire: new outcome measure for primary care

Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis

The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups.

P304

363-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.71.3.363

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P577

2001-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11833164

http://www.w3.org/2001/XMLSchema#string

P698

11511712

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

1737568

http://www.w3.org/2001/XMLSchema#string